Yelekenova, A.Bektur, C.Nurgozhin, T.2015-11-052015-11-0520149786018046728http://nur.nu.edu.kz/handle/123456789/794This study is aimed to determine cost-effectiveness of vildagliptin in comparison with sitagliptin for the treatment of patients with type 2 diabetes mellitus (T2DM) from the perspective of Ministry of Health of the Republic of Kazakhstan.enpharmacoeconomicanalysisdiabetesmetformintherapyAbstract